AlQudari Elham A, Alabdan Lulwah I, Alkhathami Abdulla A, Alotaibi Mohammed D, Alhamzi Hanan A
Department of Medicine, Prince Mohammed bin Abdulaziz Hospital, Riyadh, SAU.
Cureus. 2022 Jan 15;14(1):e21279. doi: 10.7759/cureus.21279. eCollection 2022 Jan.
Adult-onset Still's disease (AOSD) is a rare autoimmune disorder without clear etiology. It is known that genetic and infectious causes trigger diseases. AOSD cases have been reported after coronavirus disease 2019 (COVID-19) infection and post influenza vaccine. Here, we report this challenging case of adult-onset Still's disease in a patient who recently received the ChAdOx1 nCoV-19 vaccine (Oxford-AstraZeneca).
成人斯蒂尔病(AOSD)是一种病因不明的罕见自身免疫性疾病。已知遗传和感染因素可引发疾病。有报道称,2019冠状病毒病(COVID-19)感染后及接种流感疫苗后出现了成人斯蒂尔病病例。在此,我们报告了一例近期接种了ChAdOx1 nCoV-19疫苗(牛津-阿斯利康)的成人斯蒂尔病患者的具有挑战性的病例。